RxDoctor Payments Data

Rudolph Leibel

Pediatrics · New York, NYNPI 1891972402

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $43,758 of the $67,407 with a category attached, or 64.9%. 9 manufacturers reported payments, led by Pfizer at 31.9% of the total. Reporting peaked in 2019 at $17,103 and has fallen 52.9% since, to $8,061 in 2025. Among pediatrics clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$67,407in general payments, 2019–2025

Across 28 payments — averaging $2407.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$22K
  • Eli Lilly$13K
  • Merck$12K
  • AbbVie$7K
  • Janssen Research & Development, LLC$5K
  • Boehringer Ingelheim International GmbH$5K
  • plus $5K from 3 others
$975,377in research payments, 2019–2025

Across 4 payments — averaging $243,844 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi$899K
  • Regeneron$76K

What the payments were for

  • Consulting fees$43,75865%
  • Speaking & faculty fees$9,10014%
  • Grants$11,90518%
  • Travel & lodging$2,1603%
  • Food & beverage$4831%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$67,407 in reported general payments places this provider in the 95th percentile of 4,055 pediatrics providers in New York.

See all pediatrics providers in New York →

Other pediatrics in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →